A great editorial on why FDA should expand approval for all formulations of buprenorphine to treat cancer pain.

https://jamanetwork.com/journals/jamaoncology/fullarticle/2835046?guestAccessKey=6389434f-10d8-488d-a760-d22a929dcf99&utm_source=postup_jn&utm_medium=email&utm_campaign=article_alert-jamanetwork&utm_content=most_viewed-tfl_&utm_term=061525

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service